219 related articles for article (PubMed ID: 20557319)
21. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.
Kim KS; Kim SK; Lee YK; Park SW; Cho YW
Diabet Med; 2008 Aug; 25(8):997-1000. PubMed ID: 18959616
[TBL] [Abstract][Full Text] [Related]
22. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose?
Yu EY; Wong CK; Ho SY; Wong SY; Lam CL
Fam Pract; 2015 Dec; 32(6):631-8. PubMed ID: 26467644
[TBL] [Abstract][Full Text] [Related]
23. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
Gołembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
25. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.
Bao C; Zhang D; Sun B; Lan L; Cui W; Xu G; Sui C; Wang Y; Zhao Y; Wang J; Li H
PLoS One; 2015; 10(3):e0119510. PubMed ID: 25785585
[TBL] [Abstract][Full Text] [Related]
26. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
[TBL] [Abstract][Full Text] [Related]
27. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
[TBL] [Abstract][Full Text] [Related]
28. Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese.
Ko GT; Chan JC; Lau E; Woo J; Cockram CS
Diabetes Care; 1997 Feb; 20(2):170-2. PubMed ID: 9118766
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the new fasting plasma glucose cutpoint of 7.0 mmol/l in detection of diabetes mellitus in the Thai population.
Nitiyanant W; Ploybutr S; Sriussadaporn S; Yamwong P; Vannasaeng S
Diabetes Res Clin Pract; 1998 Sep; 41(3):171-6. PubMed ID: 9829345
[TBL] [Abstract][Full Text] [Related]
30. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
[TBL] [Abstract][Full Text] [Related]
31. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
32. [The clinical application of glycosylated hemoglobin A1c and glycated albumin values in cirrhosis patients with hyperglycemia].
Shao F; Li Q; Jia W
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):506-10. PubMed ID: 26359011
[TBL] [Abstract][Full Text] [Related]
33. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).
Furusyo N; Koga T; Ai M; Otokozawa S; Kohzuma T; Ikezaki H; Schaefer EJ; Hayashi J
Diabetologia; 2011 Dec; 54(12):3028-36. PubMed ID: 21947435
[TBL] [Abstract][Full Text] [Related]
34. A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan.
Hsu P; Ai M; Kanda E; Yu NC; Chen HL; Chen HW; Cheng MH; Kohzuma T; Schaefer EJ; Yoshida M
Atherosclerosis; 2015 Sep; 242(1):327-33. PubMed ID: 26247684
[TBL] [Abstract][Full Text] [Related]
35. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
Mula-Abed WA; Al-Naemi AH
Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
[TBL] [Abstract][Full Text] [Related]
36. Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Ninomiya T; Hata J; Hirakawa Y; Ikeda F; Fukuhara M; Hotta T; Koga M; Nakamura U; Kang D; Kitazono T; Kiyohara Y
Cardiovasc Diabetol; 2015 Jun; 14():84. PubMed ID: 26099223
[TBL] [Abstract][Full Text] [Related]
37. Burden of Diabetes and First Evidence for the Utility of HbA1c for Diagnosis and Detection of Diabetes in Urban Black South Africans: The Durban Diabetes Study.
Hird TR; Pirie FJ; Esterhuizen TM; O'Leary B; McCarthy MI; Young EH; Sandhu MS; Motala AA
PLoS One; 2016; 11(8):e0161966. PubMed ID: 27560687
[TBL] [Abstract][Full Text] [Related]
38. Association between glycemic control and birthweight with glycated albumin in Chinese women with gestational diabetes mellitus.
Li HP; Wang FH; Tao MF; Huang YJ; Jia WP
J Diabetes Investig; 2016 Jan; 7(1):48-55. PubMed ID: 26816601
[TBL] [Abstract][Full Text] [Related]
39. Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population.
Su H; Tang J; Ma X; He X; Ying L; Wang Y; Bao Y; Zhou J
J Diabetes Res; 2018; 2018():7932528. PubMed ID: 29951555
[TBL] [Abstract][Full Text] [Related]
40. The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype.
Nakagami T; Qiao Q; Tuomilehto J; Balkau B; Carstensen B; Tajima N; Iwamoto Y; Borch-Johnsen K; Borch-Jonsen K; ;
Diabetes Res Clin Pract; 2002 Jan; 55(1):35-43. PubMed ID: 11755477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
